BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
종목 코드 BLFS
회사 이름BioLife Solutions Inc
상장일Nov 22, 1989
CEOMr. Roderick De Greef
직원 수159
유형Ordinary Share
회계 연도 종료Nov 22
주소Suite 310
도시BOTHELL
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호98021
전화14254011400
웹사이트https://www.biolifesolutions.com/
종목 코드 BLFS
상장일Nov 22, 1989
CEOMr. Roderick De Greef
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음